1006-00008
· Crestline Packaging Solutions LLC · Closing
closing-funds-flow-memo.xlsx
DOCUMENT
M&A / Corporate
[sheet: Transaction Summary]
| Field | Value |
| Transaction | Asset Purchase of substantially all assets of Lakewood Regional Health Partners, LLC |
| Buyer | Crestline Packaging Solutions LLC, a Delaware limited liability company (Columbus, OH) |
| Buyer Parent / Sponsor | CPS Holdings, Inc. (C-Corp, DE) / Pinnacle River Capital Partners, LP (Chicago, IL) |
| Seller — Co-Managing Member (60%) | Dr. Raymond Alcott |
| Seller — Co-Managing Member (40%) / Medical Director | Dr. Nadia Petrosian |
| Seller Entity | Lakewood Regional Health Partners, LLC, a New York limited liability company (Rochester, NY); EIN 46-5183294 |
| Buyer EIN | 83-2947561 |
| Buyer Parent EIN | 83-2940187 |
| Sponsor EIN | 36-7829415 |
| Purchase Price | $140,000,000 |
| Closing Cash Consideration | $119,000,000 |
| Implied EBITDA Multiple | ~8.7x (TTM Adj. EBITDA of $16,100,000 as of 3/31/2025) |
| Closing Date | August 15, 2025 |
| APA Execution Date | June 16, 2025 |
| Governing Agreement | Asset Purchase Agreement dated June 16, 2025 |
| Buyer's Counsel | Calderwood & Harkness LLP (James Prentice, Responsible Partner) — 425 Lexington Avenue, 31st Floor, New York, NY 10017 |
| Seller's Counsel | Whitfield, Ames & Greer LLP (Catherine Greer, Lead Partner) — 780 Third Avenue, 22nd Floor, New York, NY 10017 |
| Senior Lender / Administrative Agent | Ironclad National Bank (Kenneth Boateng, SVP) — 301 South Tryon Street, Charlotte, NC 28202 |
| Buyer's Financial Advisor | Ridgepoint Advisory Group, LLC (Priya Chandrasekaran, Managing Director) — 600 Madison Avenue, Suite 1800, New York, NY 10022 |
| Seller's Investment Bank | Bellweather Partners LLP (Daniel Kerrigan, Partner) — 100 Federal Street, Suite 2400, Boston, MA 02110 |
| Escrow Agent | Apex Title & Escrow Services, LLC (Denise Kowalski, Escrow Officer) — 1 Penn Plaza, Suite 4210, New York, NY 10119 |
| R&W Insurer | Keystone Mutual Assurance Company (Sarah Ng, Underwriting Lead) — 140 Broadway, Suite 2800, New York, NY 10005 |
| Insurance Broker | Northern Crest Insurance Brokers, LLC (Michael Torrance) — 1 Landmark Square, Suite 508, Stamford, CT 06901 |
| Accounting / Tax Advisor (Buyer) | Hargrove & Whitaker LLP (Christine Nowak, CPA) — 1500 Market Street, Suite 3600, Philadelphia, PA 19102 |
| Healthcare Regulatory Advisor | Marchand Healthcare Regulatory Advisors, LLC (Anne-Marie Marchand) — 1225 Eye Street NW, Suite 600, Washington, D.C. 20005 |
| Benefits Consultant | Stonebridge Actuarial & Benefits Consulting, Inc. (Gregory Faulkner) — 50 State House Square, Hartford, CT 06103 |
| Environmental Consultant | Clearfield Environmental Consultants, Inc. — 225 West Jefferson Street, Suite 400, Syracuse, NY 13202 |
| Professional Liability / D&O Insurer (Tail) | Ridgeline Specialty Insurance Company — Chicago, IL |
| C&H Matter No. | 1006-00008 |
| Prepared By | Calderwood & Harkness LLP — Sandra Tung (Billing Partner), Derek Okonkwo (Lead Associate), Tiffany Rosenthal (Working Associate) |
| Date Prepared | August 14, 2025 |
| NOTE | All wire transfers to be initiated on August 15, 2025. Sources must equal Uses. All amounts in USD. |
[sheet: Sources & Uses]
Line Item
SOURCES OF FUNDS
| Incremental Term Loan | Debt | Ironclad National Bank | $84,000,000 | Per Amended Credit Agreement dated Sept. 17, 2021; Term SOFR + 425 bps, SOFR floor 0.50%; maturity Sept. 17, 2027; amortization 1.0% p.a. ($210,000/quarter) |
| Equity Contribution — Closing Cash | Equity | CPS Holdings, Inc. / Pinnacle River Capital Partners, LP | $35,000,000 | Funded by Pinnacle River Fund IV (committed capital $2.6B); portion of $56M total equity commitment |
| Equity Contribution — Buyer Transaction Expenses | Equity | CPS Holdings, Inc. / Pinnacle River Capital Partners, LP | $7,079,000 | Funded by Pinnacle River; balance of $56M equity commitment ($13,921,000) retained as reserves |
| TOTAL SOURCES | $126,079,000 | Must equal Total Uses |
USES OF FUNDS — PURCHASE PRICE
| Indemnification Escrow Deposit | Escrow | Apex Title & Escrow Services, LLC | $35,000,000 | 25% × $140M Purchase Price; Indemnification Cap = $35M; General Reps survive 18 months (exp. Feb. 15, 2027); Fundamental Reps survive 36 months (exp. Aug. 15, 2028) |
| Purchase Price Adjustment Escrow Deposit | Escrow | Apex Title & Escrow Services, LLC | $3,500,000 | 2.5% × $140M; Working Capital Target $6.2M; Collar ±$500K; True-Up Deadline Nov. 13, 2025 (Closing + 90 days) |
| Net Cash to Seller (Gross — before Seller expense deductions) | Seller Proceeds | Seller Members (see Waterfall) | $80,500,000 | $119M less escrows; see Seller Proceeds Waterfall sheet for allocation |
| Subtotal — Purchase Price Uses | $119,000,000 | Equals Closing Cash Consideration |
USES OF FUNDS — BUYER TRANSACTION EXPENSES
| Calderwood & Harkness LLP — Legal Fees | Legal | Buyer | $2,150,000 | Buyer's Counsel; engagement opened May 1, 2025 |
| Ridgepoint Advisory Group, LLC — Financial Advisory Fee | Advisory | Buyer | $1,050,000 | Buyer's Financial Advisor |
| Hargrove & Whitaker LLP — Accounting & Tax Advisory | Accounting | Buyer | $475,000 | Buyer's Accounting/Tax Advisor |
| Keystone Mutual Assurance Company — R&W Insurance Premium | Insurance | Buyer | $980,000 | R&W Policy Limit $35M (25% × PP); Retention $2.1M (1.5% × PP); Premium ~2.8% × $35M |
| Ironclad National Bank — Financing Fees | Financing | Buyer | $1,260,000 | 1.5% × $84M Incremental Term Loan |
| Ridgeline Specialty Insurance Company — Tail Professional Liability Premium | Insurance | Buyer | $475,000 | 3-year extended reporting period |
| Ridgeline Specialty Insurance Company — D&O Tail Premium | Insurance | Buyer | $120,000 | 3-year tail policy |
| Stonebridge Actuarial & Benefits Consulting, Inc. — Benefits Consulting | Consulting | Buyer | $125,000 | Benefits diligence; ~410 FTEs, 401(k) plan admin by Grandview Retirement Services |
| Clearfield Environmental Consultants, Inc. — Environmental Assessment | Consulting | Buyer | $85,000 | Phase I/II environmental assessment; owned properties appraised at $11.8M |
| Marchand Healthcare Regulatory Advisors, LLC — Regulatory Advisory | Consulting | Buyer | $150,000 | Healthcare regulatory diligence; NY DOH and PA DOH filings |
| Apex Title & Escrow Services, LLC — Escrow Agent Fees | Administrative | Buyer | $75,000 | Escrow agent services for both escrow accounts |
| Northern Crest Insurance Brokers, LLC — Insurance Brokerage Fee | Insurance | Buyer | $75,000 | R&W policy placement |
| Buyer's Share of Transfer Taxes | Tax | Buyer | $59,000 | 50% of estimated $118,000 total transfer taxes |
| Subtotal — Buyer Transaction Expenses | $7,079,000 | Funded from Pinnacle River equity contribution |
USES OF FUNDS — SELLER TRANSACTION EXPENSES (deducted from Seller Gross Proceeds)
| Bellweather Partners LLP — Success / Advisory Fee | Advisory | Seller | $2,800,000 | 2% × $140M Purchase Price; Seller's Investment Bank |
| Whitfield, Ames & Greer LLP — Legal Fees | Legal | Seller | $500,000 | Seller's Counsel |
| Seller's Share of Transfer Taxes | Tax | Seller | $59,000 | 50% of estimated $118,000 total transfer taxes |
| Subtotal — Seller Transaction Expenses | $3,359,000 | Deducted from Seller's $80.5M gross proceeds; see Waterfall | ||
| TOTAL USES | $126,079,000 | Must equal Total Sources | ||
| BALANCE CHECK (Sources − Uses) | $0 | BALANCED |
[sheet: Seller Proceeds Waterfall]
| Line Item | Amount | Recipient | Notes |
| Purchase Price | $140,000,000 | Fixed deal value | |
| Less: Assumed Liabilities (non-cash consideration) | ($21,000,000) | Imaging equipment leases ($2,870,000 — Marlowe Asset Management MEF), accrued PTO ($1,340,000), and other assumed liabilities per APA schedules | |
| Closing Cash Consideration | $119,000,000 | Cash paid at Closing | |
| Less: Indemnification Escrow | ($35,000,000) | Apex Title & Escrow Services, LLC | 25% of Purchase Price; De Minimis $75K/claim; Mini-Basket (tipping) $700K (0.5% × PP) |
| Less: Purchase Price Adjustment Escrow | ($3,500,000) | Apex Title & Escrow Services, LLC | 2.5% of Purchase Price; WC Target $6.2M; Collar ±$500K |
| Gross Cash to Seller | $80,500,000 | Available for seller distributions and seller expenses |
SELLER TRANSACTION EXPENSE DEDUCTIONS
| Less: Bellweather Partners LLP — Success Fee | ($2,800,000) | Bellweather Partners LLP | 2% × $140M; 100 Federal Street, Suite 2400, Boston, MA 02110 |
| Less: Whitfield, Ames & Greer LLP — Legal Fees | ($500,000) | Whitfield, Ames & Greer LLP | 780 Third Avenue, 22nd Floor, New York, NY 10017 |
| Less: Seller's Share of Transfer Taxes | ($59,000) | Applicable Taxing Authorities | 50% of $118,000 total estimated transfer taxes |
| Total Seller Expense Deductions | ($3,359,000) | ||
| NET CASH TO SELLER MEMBER ACCOUNTS | $77,141,000 | Distributed per LLC ownership percentages | |
| Dr. Raymond Alcott (60%) | $46,284,600 | Dr. Raymond Alcott | Co-Managing Member; 14 Tobey Trail, Pittsford, NY 14534; Consulting Agreement: $450,000/yr for 2 years post-closing |
| Dr. Nadia Petrosian (40%) | $30,856,400 | Dr. Nadia Petrosian | Co-Managing Member / Medical Director; 2801 Elmwood Avenue, Brighton, NY 14618; Consulting Agreement: $375,000/yr for 2 years post-closing |
| Total Net Cash to Seller Members | $77,141,000 | Must equal Gross Cash to Seller less Seller Expense Deductions | |
| VERIFICATION | $0 | Gross Cash to Seller ($80,500,000) − Seller Expenses ($3,359,000) − Net to Members ($77,141,000) = $0 |
[sheet: Wire Transfer Schedule]
Wire No.
INCOMING WIRES — SOURCES
| W-01 | 1 — Fund First | Ironclad National Bank | Crestline Packaging Solutions LLC — Closing Account | Incremental Term Loan proceeds per Amended Credit Agreement (Sept. 17, 2021); co-terminus maturity Sept. 17, 2027 | $84,000,000 | WI-01 | Pending |
| W-02 | 1 — Fund First | CPS Holdings, Inc. (funded by Pinnacle River Capital Partners, LP — Fund IV) | Crestline Packaging Solutions LLC — Closing Account | Equity contribution: $35,000,000 closing cash + $7,079,000 buyer transaction expenses | $42,079,000 | WI-01 | Pending |
| TOTAL INCOMING | $126,079,000 |
OUTGOING WIRES — PURCHASE PRICE / ESCROWS
| W-03 | 2 — Concurrent | Crestline Packaging Solutions LLC | Apex Title & Escrow Services, LLC — Indemnification Escrow Account | Indemnification Escrow deposit; 25% of Purchase Price; Cap $35M; General Reps expire Feb. 15, 2027; Fundamental Reps expire Aug. 15, 2028 | $35,000,000 | WI-02 | Pending |
| W-04 | 2 — Concurrent | Crestline Packaging Solutions LLC | Apex Title & Escrow Services, LLC — Purchase Price Adjustment Escrow Account | PP Adjustment Escrow deposit; 2.5% of Purchase Price; WC Target $6.2M; Collar ±$500K; True-Up Deadline Nov. 13, 2025 | $3,500,000 | WI-03 | Pending |
| W-05 | 3 — Post-Escrow | Crestline Packaging Solutions LLC | Dr. Raymond Alcott | Seller member distribution — 60% of net seller proceeds ($80.5M gross less $3.359M seller expenses) | $46,284,600 | WI-04 | Pending |
| W-06 | 3 — Post-Escrow | Crestline Packaging Solutions LLC | Dr. Nadia Petrosian | Seller member distribution — 40% of net seller proceeds ($80.5M gross less $3.359M seller expenses) | $30,856,400 | WI-05 | Pending |
| SUBTOTAL — PURCHASE PRICE / ESCROWS | $115,641,000 |
OUTGOING WIRES — SELLER TRANSACTION EXPENSES (from Seller Proceeds)
| W-07 | 3 — Post-Escrow | Crestline Packaging Solutions LLC | Bellweather Partners LLP | Seller's investment bank success fee — 2% × $140M Purchase Price | $2,800,000 | WI-06 | Pending |
| W-08 | 3 — Post-Escrow | Crestline Packaging Solutions LLC | Whitfield, Ames & Greer LLP | Seller's counsel legal fees | $500,000 | WI-07 | Pending |
| W-09 | 3 — Post-Escrow | Crestline Packaging Solutions LLC | Applicable Taxing Authorities (Seller's Portion) | Seller's 50% share of estimated transfer taxes | $59,000 | WI-08 | Pending |
| SUBTOTAL — SELLER EXPENSES | $3,359,000 |
OUTGOING WIRES — BUYER TRANSACTION EXPENSES
| W-10 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Calderwood & Harkness LLP | Buyer's counsel legal fees; Matter No. 1006-00008 | $2,150,000 | WI-09 | Pending |
| W-11 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Ridgepoint Advisory Group, LLC | Buyer's financial advisory fee | $1,050,000 | WI-10 | Pending |
| W-12 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Hargrove & Whitaker LLP | Buyer's accounting and tax advisory fees | $475,000 | WI-11 | Pending |
| W-13 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Keystone Mutual Assurance Company | R&W insurance premium; Policy Limit $35M; Retention $2.1M (1.5% × PP); ~2.8% rate-on-line | $980,000 | WI-12 | Pending |
| W-14 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Ironclad National Bank | Financing fees — 1.5% × $84M Incremental Term Loan | $1,260,000 | WI-13 | Pending |
| W-15 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Ridgeline Specialty Insurance Company | Tail professional liability / malpractice insurance premium — 3-year extended reporting period | $475,000 | WI-14 | Pending |
| W-16 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Ridgeline Specialty Insurance Company | D&O tail insurance premium — 3-year tail | $120,000 | WI-14 | Pending |
| W-17 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Stonebridge Actuarial & Benefits Consulting, Inc. | Benefits consulting and actuarial diligence fees | $125,000 | WI-15 | Pending |
| W-18 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Clearfield Environmental Consultants, Inc. | Environmental site assessment fees (Rochester Main and Syracuse owned properties) | $85,000 | WI-16 | Pending |
| W-19 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Marchand Healthcare Regulatory Advisors, LLC | Healthcare regulatory advisory fees; NY DOH / PA DOH filing support | $150,000 | WI-17 | Pending |
| W-20 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Apex Title & Escrow Services, LLC | Escrow agent administrative fees | $75,000 | WI-18 | Pending |
| W-21 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Northern Crest Insurance Brokers, LLC | Insurance brokerage fee for R&W policy placement | $75,000 | WI-19 | Pending |
| W-22 | 4 — Post-Closing | Crestline Packaging Solutions LLC | Applicable Taxing Authorities (Buyer's Portion) | Buyer's 50% share of estimated transfer taxes | $59,000 | WI-20 | Pending |
| SUBTOTAL — BUYER TRANSACTION EXPENSES | $7,079,000 | ||||||
| TOTAL OUTGOING | $126,079,000 | ||||||
| BALANCE CHECK (Incoming − Outgoing) | $0 | BALANCED |
[sheet: Transaction Expenses]
Expense Item
BUYER TRANSACTION EXPENSES
| Buyer's Counsel — Legal Fees | Calderwood & Harkness LLP | Legal | Buyer | $2,150,000 | 1.54% | Responsible Partner: James Prentice ($1,450/hr); Billing Partner: Sandra Tung ($1,350/hr); Specialist Partner (Tax): Sylvia Hartwell ($1,400/hr); Lead Associate: Derek Okonkwo ($875/hr); Working Associate: Tiffany Rosenthal ($725/hr) |
| Buyer's Financial Advisory Fee | Ridgepoint Advisory Group, LLC | Advisory | Buyer | $1,050,000 | 0.75% | Engagement Lead: Priya Chandrasekaran, Managing Director |
| Accounting & Tax Advisory | Hargrove & Whitaker LLP | Accounting | Buyer | $475,000 | 0.34% | Engagement Partner: Christine Nowak, CPA |
| R&W Insurance Premium | Keystone Mutual Assurance Company | Insurance | Buyer | $980,000 | 0.70% | Policy Limit $35M; Retention $2.1M; Rate ~2.8% on $35M limit; Underwriting Lead: Sarah Ng; Bermuda domicile, US office 140 Broadway, Ste 2800, NY |
| Financing Fees | Ironclad National Bank | Financing | Buyer | $1,260,000 | 0.90% | 1.5% of $84M Incremental Term Loan; existing $50M Revolver (undrawn); SVP: Kenneth Boateng |
| Tail Professional Liability Premium | Ridgeline Specialty Insurance Company | Insurance | Buyer | $475,000 | 0.34% | 3-year extended reporting period covering 38 physicians, 24 NP/PAs across 11 clinic locations |
| D&O Tail Premium | Ridgeline Specialty Insurance Company | Insurance | Buyer | $120,000 | 0.09% | 3-year tail for pre-closing directors & officers |
| Benefits Consulting | Stonebridge Actuarial & Benefits Consulting, Inc. | Consulting | Buyer | $125,000 | 0.09% | Diligence of benefit plans for ~410 FTEs; Lead: Gregory Faulkner |
| Environmental Assessment | Clearfield Environmental Consultants, Inc. | Consulting | Buyer | $85,000 | 0.06% | Phase I/II for owned properties: Rochester Main ($6.9M appraised) and Syracuse ($4.9M appraised) |
| Healthcare Regulatory Advisory | Marchand Healthcare Regulatory Advisors, LLC | Consulting | Buyer | $150,000 | 0.11% | NY DOH & PA DOH filing preparation; CMS certification transfers (11 locations); Lead: Anne-Marie Marchand |
| Escrow Agent Fees | Apex Title & Escrow Services, LLC | Administrative | Buyer | $75,000 | 0.05% | Administration of Indemnification Escrow ($35M) and PP Adjustment Escrow ($3.5M); Officer: Denise Kowalski |
| Insurance Brokerage Fee | Northern Crest Insurance Brokers, LLC | Insurance | Buyer | $75,000 | 0.05% | R&W policy placement and negotiation; Account Exec: Michael Torrance |
| Buyer's Transfer Taxes | Applicable Taxing Authorities | Tax | Buyer | $59,000 | 0.04% | 50% of estimated $118,000; split equally per APA |
| SUBTOTAL — BUYER EXPENSES | Buyer | $7,079,000 | 5.06% | Funded from Pinnacle River equity contribution (expense/reserve tranche) |
SELLER TRANSACTION EXPENSES
| Seller's Investment Bank — Success Fee | Bellweather Partners LLP | Advisory | Seller | $2,800,000 | 2.00% | 2% × $140M Purchase Price; Engagement Lead: Daniel Kerrigan, Partner |
| Seller's Counsel — Legal Fees | Whitfield, Ames & Greer LLP | Legal | Seller | $500,000 | 0.36% | Lead Partner: Catherine Greer; Senior Associate: Tomás Delgado |
| Seller's Transfer Taxes | Applicable Taxing Authorities | Tax | Seller | $59,000 | 0.04% | 50% of estimated $118,000; split equally per APA |
| SUBTOTAL — SELLER EXPENSES | Seller | $3,359,000 | 2.40% | Deducted from Seller's gross cash proceeds at Closing | ||
| TOTAL ESTIMATED TRANSACTION EXPENSES | Combined | $10,438,000 | 7.46% | $10,438,000 ÷ $140,000,000 = 7.46% |
[sheet: Key Deal Parameters]
| Parameter | Value | Formula / Basis | Expiration / Key Date |
| Purchase Price | $140,000,000 | Fixed | N/A |
| Closing Cash Consideration | $119,000,000 | $84M debt + $35M equity | August 15, 2025 |
| Non-Cash Consideration (Assumed Liabilities) | ~$21,000,000 | $140M − $119M | At Closing |
| Indemnification Escrow | $35,000,000 | 25% × $140,000,000 | Released per APA terms |
| Indemnification Cap | $35,000,000 | 25% × $140,000,000 | Coextensive with survival |
| PP Adjustment Escrow | $3,500,000 | 2.5% × $140,000,000 | Released post-true-up |
| Working Capital Target | $6,200,000 | Per agreed methodology | N/A |
| Working Capital Collar | ±$500,000 | No adjustment within band | N/A |
| Working Capital True-Up Deadline | November 13, 2025 | Closing + 90 calendar days | November 13, 2025 |
| De Minimis Threshold (per claim) | $75,000 | Fixed | N/A |
| Mini-Basket (Tipping) | $700,000 | 0.5% × $140,000,000 | N/A |
| General Reps Survival | 18 months | Per APA | February 15, 2027 |
| Fundamental Reps Survival | 36 months | Per APA | August 15, 2028 |
| R&W Policy Limit | $35,000,000 | 25% × $140,000,000 | Coextensive with reps |
| R&W Policy Retention | $2,100,000 | 1.5% × $140,000,000 | N/A |
| Non-Compete Duration | 3 years post-closing | Per APA | August 15, 2028 |
| Non-Compete Radius | 75 miles from any Lakewood clinic | Per APA | N/A |
| Dr. Alcott Consulting Agreement | $450,000/year for 2 years | Per APA | August 15, 2027 |
| Dr. Petrosian Consulting Agreement | $375,000/year for 2 years | Per APA | August 15, 2027 |
| Incremental Term Loan Maturity | September 17, 2027 | Co-terminus with existing facility | September 17, 2027 |
| Term Loan Interest Rate | Term SOFR + 425 bps; floor 0.50% | Per Credit Agreement | N/A |
| Quarterly Amortization | $210,000 | $84M × 1.0% ÷ 4 | Quarterly |
| Existing Revolver Availability | $50,000,000 (undrawn) | Per Credit Agreement | N/A |
| OIG Inquiry — Syracuse Facility | $350,000 – $900,000 estimated exposure | CPT 99214 upcoding investigation | Pending |
| Accrued PTO (Assumed) | $1,340,000 | Estimated at closing | At Closing |
| Imaging Equipment Leases (Assumed) | $2,870,000 | 3 Marlowe Asset Management MEF leases | March 2026 – November 2027 |
| EHR License (Clearpath) | $840,000/year | License No. CP-ENT-2022-0487 | December 31, 2027 |
| Meridian Shield Revenue Concentration | ~$17,248,000/yr (22%) | 22% × $78.4M TTM revenue | Ongoing payor contract |